Value Sense
AMGN
Amgen Inc. (AMGN)
Last Price$324.92.2%
Market Cap$175.6B
LTM Revenue
$33.3B
+18.2% YoY
LTM Net Income
$4,090.0M
-39.1% YoY
LTM Net Debt
$48.1B
Net Debt to FCF - 4.6x
LTM Free Cash Flow (FCF)
$10.4B
31.2% margin

AMGN Income Statement

AMGN Income Statement Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Revenue
$33.4B 18.6% YoY
Gross profit
$20.6B 4.0% YoY
61.5% margin
Cost of revenue
$12.9B 52.8% YoY
Operating income
$7,258.0M (8.1%) YoY
21.7% margin
Other: $506.0M
Net interest: $3,155.0M
Operating expenses
$13.3B 12.0% YoY
Pre-tax income
$4,609.0M (41.3%) YoY
13.8% margin
Net income
$4,090.0M (39.1%) YoY
12.2% margin
Income tax
$519.0M
11.3% tax rate
R&D
$5,964.0M 24.7% YoY
17.8% of revenue
SG&A
$7,096.0M 14.8% YoY
21.2% of revenue

AMGN Income statement key metrics

Annual
Quarterly
LTM

Revenue

$33.4B +18.6% YoY

Operating Income

$7.3B -8.1% YoY

Net Income

$4.1B -39.1% YoY

AMGN Balance Sheet

AMGN Balance Sheet Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$91.8B
Current assets ($29.0B, 31.6% of total)
Cash & ST investments
$12.0B (13.0%)
Accounts receivables
$6,782.0M (7.4%)
Other current assets
$10.3B (11.2%)
Non-current assets ($62.8B, 68.4% of total)
Intangible assets
$27.7B (30.2%)
Other non-current assets
$28.6B (31.1%)
Financial position
Net Debt
$48.1B
$12.0B$60.1B
Cash & Short-term Investments
Total Debt
Quick ratio
0.8x
Net Debt to Free Cash Flow
4.6x
Debt to Equity ratio
1,022.6%

AMGN Balance Sheet Metrics

Annual
Quarterly
LTM

Assets

$91.8B -5.5% YoY

Liabilities

$86.0B -5.5% YoY

Shareholder's Equity

$5,877.0M -5.7% YoY

AMGN Cash Flow Statement

AMGN Cash Flow Statement Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Cash Beginning of PeriodOperating Cash FlowInvesting Cash FlowFinancing Cash FlowForex Changes on CashCash End of Period$10.9B$11.5B($1,046.0M)($9,415.0M)$0.0$12.0B

AMGN Cash Flow Statement key metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$11.5B +35.6% YoY

Capital Expenditure (CAPEX)

($1,096.0M) -1.4% YoY

Free Cash Flow (FCF)

$10.4B +41.2% YoY

AMGN Financials

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
12,430.0
17.8%
14,268.0
14.8%
14,771.0
3.5%
15,003.0
1.6%
14,642.0
(2.4%)
15,053.0
2.8%
15,582.0
3.5%
17,265.0
10.8%
18,676.0
8.2%
20,063.0
7.4%
21,662.0
8.0%
22,991.0
6.1%
22,849.0
(0.6%)
23,747.0
3.9%
23,362.0
(1.6%)
25,424.0
8.8%
25,979.0
2.2%
26,323.0
1.3%
28,190.0
7.1%
33,424.0
18.6%
Cost of Goods Sold (COGS)2,082.02,095.02,548.02,296.02,091.02,220.02,427.02,918.03,346.04,422.04,227.04,162.04,069.04,101.04,356.06,159.06,454.06,406.08,415.012,858.0
Gross Profit
% margin
10,348.0
83.3%
12,173.0
85.3%
12,223.0
82.7%
12,707.0
84.7%
12,551.0
85.7%
12,833.0
85.3%
13,155.0
84.4%
14,347.0
83.1%
15,330.0
82.1%
15,641.0
78.0%
17,435.0
80.5%
18,829.0
81.9%
18,780.0
82.2%
19,646.0
82.7%
19,006.0
81.4%
19,265.0
75.8%
19,525.0
75.2%
19,917.0
75.7%
19,775.0
70.1%
20,566.0
61.5%
Operating Expenses5,500.07,102.07,444.07,493.07,045.07,288.08,843.08,770.09,463.09,450.08,965.09,035.08,807.09,383.09,332.010,126.010,381.010,351.011,878.013,308.0
Research & Development Expenses (R&D)2,314.03,366.03,266.03,030.02,864.02,894.03,167.03,380.04,083.04,297.04,070.03,840.03,562.03,737.04,116.04,207.04,819.04,434.04,784.05,964.0
Selling, General & Administrative Expenses (SG&A)2,790.03,366.03,361.03,789.03,820.03,983.04,486.04,801.05,184.04,699.04,846.05,062.04,870.05,332.05,150.05,730.05,368.05,414.06,179.07,096.0
Operating Income
% margin
4,848.0
39.0%
3,840.0
26.9%
3,980.0
26.9%
5,214.0
34.8%
5,506.0
37.6%
5,545.0
36.8%
4,312.0
27.7%
5,577.0
32.3%
5,867.0
31.4%
6,191.0
30.9%
8,470.0
39.1%
9,794.0
42.6%
9,973.0
43.6%
10,263.0
43.2%
9,674.0
41.4%
5,794.0
22.8%
6,005.0
23.1%
5,335.0
20.3%
7,897.0
28.0%
7,258.0
21.7%
Interest Income0.00.00.0145.0276.0376.0448.0485.0420.0465.0603.0629.0928.0674.0753.0256.01,197.01,406.00.00.0
Interest Expense29.02,282.02,136.0344.0578.0604.0610.01,053.01,022.01,071.01,095.01,260.01,304.01,392.01,289.01,262.01,197.01,406.02,875.03,155.0
Pre-tax Income4,868.04,020.03,961.05,250.05,204.05,317.04,150.05,009.05,265.05,585.07,978.09,163.09,597.09,545.09,138.08,133.06,701.07,346.07,855.04,609.0
Income Tax
% effective tax rate
1,194.0
24.5%
1,070.0
26.6%
795.0
20.1%
1,054.0
20.1%
599.0
11.5%
690.0
13.0%
467.0
11.3%
664.0
13.3%
184.0
3.5%
427.0
7.6%
1,039.0
13.0%
1,441.0
15.7%
7,618.0
79.4%
1,151.0
12.1%
1,296.0
14.2%
869.0
10.7%
808.0
12.1%
794.0
10.8%
1,138.0
14.5%
519.0
11.3%
Net Income
% margin
3,674.0
29.6%
2,950.0
20.7%
3,166.0
21.4%
4,196.0
28.0%
4,605.0
31.5%
4,627.0
30.7%
3,683.0
23.6%
4,345.0
25.2%
5,081.0
27.2%
5,158.0
25.7%
6,939.0
32.0%
7,722.0
33.6%
1,979.0
8.7%
8,394.0
35.3%
7,842.0
33.6%
7,264.0
28.6%
5,893.0
22.7%
6,552.0
24.9%
6,717.0
23.8%
4,090.0
12.2%
EPS2.972.512.833.794.534.824.075.616.756.809.1510.322.7112.7012.9612.4010.3412.1812.567.56
Diluted EPS2.932.482.823.774.514.794.045.526.646.709.0610.242.6912.6212.8812.3110.2812.1112.497.56
EBITDA
% margin
5,689.0
45.8%
7,265.0
50.9%
5,981.0
40.5%
6,639.0
44.3%
6,580.0
44.9%
6,671.0
44.3%
5,054.0
32.4%
6,356.0
36.8%
7,391.0
39.6%
8,747.0
43.6%
11,132.0
51.4%
11,937.0
51.9%
12,804.0
56.0%
12,883.0
54.3%
12,633.0
54.1%
12,929.0
50.9%
12,542.0
48.3%
12,093.0
45.9%
14,702.0
52.2%
15,686.0
46.9%

FAQ

What is the Amgen Inc. (AMGN) revenue?

The Amgen Inc. (AMGN) revenue is $33.4B, reflecting a year-over-year (YoY) growth of +18.6% YoY.

What is the Amgen Inc. (AMGN) Net Income?

The Amgen Inc. (AMGN) Net Income is $4,090.0M, showcasing a YoY growth of -39.1% YoY.